ANGVUZI

Welcome to the Brand page for “ANGVUZI”, which is offered here for Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for cholesterol level reduction; pharmaceutical preparations for triglyceride level reduction;.

Its status is currently believed to be active. Its class is unavailable. “ANGVUZI” is believed to be currently owned by “Pfizer Inc.”